… This review summarizes the available clinical data from Asian countries, with the intention
of formulating an appropriate and actionable stroke prevention strategy for AF in Asia. …

… on stroke prevention among patients with AF focused on the Asia region, regarding stroke
and … of decision-making process of stroke prevention in patients with AF from Asia (Figure 1). …

… have a history of previous stroke. Clinical challenges are evident in the field of stroke
prevention in AF, amongst Asians. Existing stroke and bleeding risk scores have not been well-…

… , higher prevalence of previous stroke, and lower creatinine clearance may increase stroke
risk in Asians. Although on VKA treatment, previous stroke and Asian race are major risks of …

… or systemic embolism than non-Asians, irrespective of treatment group. However, in contrast
… in Asian patients receiving warfarin were only slightly greater than in non-Asian patients …

… Type 2 diabetes was diagnosed in ∼20–30% of patients (Figure 1D). Asian patients had a
higher prevalence of previous stroke or transient ischaemic attack than non-Asians (Figure 1E…

… The meta-analysis shows that the DOACs had greater effectiveness and safety compared
to warfarin in real-world practice for stroke prevention, among Asian patients with NVAF. …

… in various outcomes between Asian and non-Asian patients. … of NOACs in Asian patients
compared with non-Asian patients that … 27 Thus, these data are new and important for patients, …

… global trials, and substantial numbers of patients from Asian countries were participants. …
stroke prevention in Asian patients with AF, with particular focus on the data on NOACs in Asians…

… Major clinical outcomes in Asian and non-Asian patients from the four large-scale randomized
clinical trial comparing NOACs with VKAs for stroke prevention in AF. Data are taken from …